Premarketing submission made to FDA to demonstrate that the device to be marketed is as safe and effective, that is, substantially equivalent (SE), to a legally marketed device that is not subject to premarket approval (PMA).
Page(s): < > 1 2
 
Reference Product Name Price
510(k)
A224101
 BIOPHEN™ UFH Control C1 $175.00
510(k)
A224201
 BIOPHEN™ LMWH Control C4 $175.00
510(k)
A224301
 BIOPHEN™ LMWH Control Low Cl $175.00
510(k)
A223301
 BIOPHEN™ Abnormal Control Plasma (IVD) $175.00